Cited by 1,268Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

Näslund, Jan·2000·JAMA

DOI 10.1001/jama.283.12.1571

Open this paper in CoChat — free account

Abstract

CONTEXT: Alzheimer disease (AD) is characterized neuropathologically by the presence of amyloid beta-peptide (Abeta)-containing plaques and neurofibrillary tangles composed of abnormal tau protein. Considerable controversy exists as to whether the extent of accumulation of Abeta correlates with dementia and whether Abeta alterations precede or follow changes in tau. OBJECTIVES: To determine whether accumulation of Abeta correlates with the earliest signs of cognitive deterioration and to define the relationship between Abeta accumulation and early tau changes. DESIGN, SETTING, AND PATIENTS: Postmortem cross-sectional study of 79 nursing home residents with Clinical Dementia Rating (CDR) scale scores of 0.0 to 5.0 who died between 1986 and 1997, comparing the levels of Abeta variants in the cortices of the subjects with no (CDR score, 0.0 [n = 16]), questionable (CDR score, 0.5 [n = 11]), mild (CDR score, 1.0 [n = 22]), moderate (CDR score, 2.0 [n = 15]), or severe (CDR score, 4.0 or 5.0 [n = 15]) dementia. MAIN OUTCOME MEASURES: Levels of total Abeta peptides with intact or truncated amino termini and ending in either amino acid 40 (A(beta)x-40) or 42 (A(beta)x-42) in 5 neocortical brain regions as well as levels of tau protein undergoing early conformational changes in frontal cortex, as a function of CDR score. RESULTS: The levels of both A(beta)x-40 and A(beta)x-42 were elevated even in cases classified as having questionable dementia (CDR score = 0.5), and increases of both peptides correlated with progression of dementia. Levels of the more fibril-prone A(beta)x-42 peptide were higher than those of A(beta)x-40 in nondemented cases and remained higher throughout progression of disease in all regions examined. Finally, increases in A(beta)x-40 and A(beta)x-42 precede significant tau pathology at least in the frontal cortex, an area chosen for examination because of the absence of neuritic changes in the absence of disease. CONCLUSIONS: In this study, levels of total A(beta)x-40 and A(beta)x-42 were elevated early in dementia and levels of both peptides were strongly correlated with cognitive decline. Of particular interest, in the frontal cortex, Abeta was elevated before the occurrence of significant tau pathology. These results support an important role for Abeta in mediating initial pathogenic events in AD dementia and suggest that treatment strategies targeting the formation, accumulation, or cytotoxic effects of Abeta should be pursued.

Integrity signals

Registry

Crossref · 10.1001/jama.283.12.1571

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 953
Alzheimer's Disease--Genotypes, Phenotype, and Treatments
Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 879
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Tau protein pathology in neurodegenerative diseases
Spillantini, M. G., & Goedert, M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01337-x · Cited by 683
Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits
Bierer, L. M., Haroutunian, V. H., Gabriel, S., Knott, P. J., Carlin, L. S., Purohit, D. P., Perl, D. P., Schmeidler, J., Kanof, P. D., & Davis, K. L. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020749.x · Cited by 580

Show all 28 references

Sorted by citations

Items 601–700 of 1,000

Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer’s disease
Pistell, P. J., Zhu, M., & Ingram, D. K. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.025 · Cited by 47
Down‐regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease
Rodriguez‐Perdigon, M., Tordera, R. M., Gil-Bea, F. J., Gereñu, G., Ramírez, M. J., & Solas, M. (2016) · Hippocampus · doi:10.1002/hipo.22607 · Cited by 49
Biotin, coenzyme Q10, and their combination ameliorate aluminium chloride‐induced Alzheimer's disease via attenuating neuroinflammation and improving brain insulin signaling
Attia, H., Albuhayri, S., Alaraidh, S., Alotaibi, A., Yacoub, H. I., Mohamad, R. A., & Alamin, M. A. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22519 · Cited by 47
Alleviation of Aβ-induced cognitive impairment by ultrasound-mediated gene transfer of HGF in a mouse model
Takeuchi, D., Sato, N., Shimamura, M., Kurinami, H., Takeda, S., Shinohara, M., Suzuki, S., Kojima, M., Ogihara, T., & Morishita, R. (2008) · Gene Therapy · doi:10.1038/sj.gt.3303094 · Cited by 47
Magnetic resonance and PET studies in the early diagnosis of Alzheimer’s disease
Mosconi, L., De Santi, S., Rusinek, H., Convit, A., & de Leon, M. J. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.5.831 · Cited by 46
Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-Aβ Antibodies
Sehlin, D., Hedlund, M., Lord, A., Englund, H., Gellerfors, P., Paulie, S., Lannfelt, L., & Pettersson, F. E. (2010) · Neurodegenerative Diseases · doi:10.1159/000316530 · Cited by 47
Benzophenone-based derivatives: A novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation
Belluti, F., Bartolini, M., Bottegoni, G., Bisi, A., Cavalli, A., Andrisano, V., & Rampa, A. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.02.019 · Cited by 46
Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents
Luo, W., Su, Y., Chen, H., Tian, R.-G., Su, L.-P., Wang, Y., Yang, L., Yue, J., & Wang, C. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.061 · Cited by 46
Observation of Reduced Cytotoxicity of Aggregated Amyloidogenic Peptides with Chaperone-like Molecules
Liu, L., Zhang, L., Niu, L., Xu, M., Mao, X., Yang, Y., & Wang, C. (2011) · ACS Nano · doi:10.1021/nn201773x · Cited by 46
Postmortem Indices Linking Risk Factors to Cognition
Bennett, D. A. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200607001-00009 · Cited by 46
Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers
Adwan, L. I., Subaiea, G. M., & Zawia, N. H. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.009 · Cited by 45
Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model
Rönnbäck, A., Zhu, S., Dillner, K., Aoki, M., Lilius, L., Näslund, J., Winblad, B. G., & Graff, C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.021 · Cited by 47
Self-citation
Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-β peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease
Li, J., Liu, C., Wei, N., Li, X., Liu, Y.-Y., Yang, R., & Jia, Y. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.011 · Cited by 45
Disease-Modifying Effects of M1 Muscarinic Acetylcholine Receptor Activation in an Alzheimer’s Disease Mouse Model
Lebois, E. P., Schroeder, J. P., Esparza, T. J., Bridges, T. M., Lindsley, C. W., Conn, P. J., Brody, D. L., Daniels, J. S., & Levey, A. I. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00278 · Cited by 45
Genetic Dissection of Alzheimer’s Disease Using Drosophila Models
Jeon, Y., Lee, J., Choi, B., Won, S.-Y., & Cho, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030884 · Cited by 46
Memory performance is related to amyloid and tau pathology in the hippocampus
Reitz, C., Honig, L. S., Vonsattel, J. P., Tang, M.-X., & Mayeux, R. P. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.154146 · Cited by 49
Amyloid Imaging: From Benchtop to Bedside
Wu, C., Pike, V. W., & Wang, Y. (2005) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)70008-9 · Cited by 45
Air Pollution and Traffic Noise Interact to Affect Cognitive Health in Elderly Hispanics
Yu, Y., Su, J. G., Jerrett, M., Paul, K. C., Lee, E. Y., Shih, I., Haan, M. N., & Ritz, B. R. (2022) · Environment International · doi:10.1016/j.envint.2023.107810 · Cited by 44
The Role of β-Amyloid Protein in Synaptic Function: Implications for Alzheimers Disease Therapy
Peña‐Ortega, F., Gutiérrez-Lerma, A. I., Quiroz‐Baez, R., & Arias, C. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359531 · Cited by 45
Observations in APP Bitransgenic Mice Suggest that Diffuse and Compact Plaques Form via Independent Processes in Alzheimer's Disease
Lord, A., Philipson, O., Klingstedt, T., Westermark, G. T., Hammarström, P., Nilsson, K. P. R., & Nilsson, L. N. G. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.052 · Cited by 46
Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases
Schepici, G., Silvestro, S., Trubiani, O., Bramanti, P., & Mazzon, E. (2020) · Brain Sciences · doi:10.3390/brainsci10040245 · Cited by 44
Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice
Subaiea, G. M., Adwan, L. I., Ahmed, A. H., Stevens, K. E., & Zawia, N. H. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.002 · Cited by 45
Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease
Tremblay, C., François, A., Delay, C., Freland, L., Vandal, M., Bennett, D. A., & Calon, F. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw109 · Cited by 49
Potential Treatment Opportunities for Alzheimer's Disease Through Inhibition of Secretases and Aβ Immunization
Schenk, D., Games, D., & Seubert, P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:259 · Cited by 44
Amyloid neuropathology in the single Arctic APP transgenic model affects interconnected brain regions
Rönnbäck, A., Sagelius, H., Bergstedt, K. D., Näslund, J., Westermark, G. T., Winblad, B., & Graff, C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.07.012 · Cited by 43
Self-citation
Glimepiride protects neurons against amyloid-β-induced synapse damage
Osborne, C., West, E., Nolan, W., McHale-Owen, H., Williams, A., & Bate, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.030 · Cited by 43
Amyloid β‐peptide activates nuclear factor‐κB through an N‐methyl‐D‐aspartate signaling pathway in cultured cerebellar cells
Kawamoto, E. M., Lepsch, L. B., Cury‐Boaventura, M. F., Munhoz, C. D., Lima, L. S., Yshii, L., Avellar, M. C. W., Curi, R., Mattson, M. P., & Scavone, C. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21548 · Cited by 43
Abnormal kalirin signaling in neuropsychiatric disorders
Remmers, C. L., Sweet, R. A., & Penzes, P. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.12.006 · Cited by 45
Sildenafil Decreases BACE1 and Cathepsin B Levels and Reduces APP Amyloidogenic Processing in the SAMP8 Mouse
Orejana, L., Barros-Miñones, L., Jordán, J., Cedazo-Mı́nguez, Á., Tordera, R. M., Aguirre, N., & Puerta, E. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu106 · Cited by 42
Alzheimer’s Disease and the Blood–Brain Barrier: Past, Present and Future
Bowman, G. L., & Quinn, J. F. (2008) · Aging Health · doi:10.2217/1745509x.4.1.47 · Cited by 43
Adult Astrogenesis and the Etiology of Cortical Neurodegeneration
Mohn, T. C., & Koob, A. O. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25520 · Cited by 44
Dysfunctional γ-Secretase in Familial Alzheimer’s Disease
Wolfe, M. S. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2511-1 · Cited by 47
X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide
Summers, K. L., Schilling, K. M., Roseman, G. P., Markham, K. A., Dolgova, N. V., Kröll, T., Sokaras, D., Millhauser, G. L., Pickering, I. J., & George, G. N. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b00507 · Cited by 42
Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers
Dufort‐Gervais, J., Provost, C., Charbonneau, L., Norris, C. M., Calon, F., Mongrain, V., & Brouillette, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-63255-6 · Cited by 48
Detection of Amyloid Plaques by Radioligands for Aβ40 and Aβ42: Potential Imaging Agents in Alzheimer's Patients
Kung, M., Skovronsky, D., Hou, C., Zhuang, Z., Gur, T., Zhang, B., Trojanowski, J. Q., Lee, V. M. ‐., & Kung, H. F. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:1:15 · Cited by 42
Personality Factors Moderate the Associations Between Apolipoprotein Genotype and Cognitive Function as Well as Late Onset Alzheimer Disease
Dar‐Nimrod, I., Chapman, B. P., Franks, P. J., Robbins, J. A., Porsteinsson, A. P., Mapstone, M. E., & Duberstein, P. R. (2012) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318267016b · Cited by 41
Intraneuronal Aβ as a trigger for neuron loss: can this be translated into human pathology?
Bayer, T. A., & Wirths, O. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390857 · Cited by 41
Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillization
Bonito-Oliva, A., Barbash, S., Sakmar, T. P., & Graham, W. V. (2017) · Scientific Reports · doi:10.1038/srep42880 · Cited by 41
MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer’s disease cell model
Zhong, Z., Yuan, K., Tong, X., Hu, J., Song, Z., Zhang, G., Fang, X., & Zhang, W. (2018) · Neuroreport · doi:10.1097/wnr.0000000000001118 · Cited by 41
Alteration of the Wnt/GSK3β/β‑catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model
Chen, J., Long, Z., Li, Y., Luo, M., Luo, S., & He, G. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4198 · Cited by 42
Prolonged isolation stress accelerates the onset of Alzheimer’s disease-related pathology in 5xFAD mice despite running wheels and environmental enrichment
Peterman, J. L., White, J. D., Calcagno, A., Hagen, C. W., Quiring, M. E., Paulhus, K., Gurney, T., Eimerbrink, M. J., Curtis, M., Boehm, G. W., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112366 · Cited by 41
Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients
Bjorkli, C., Sandvig, A., & Sandvig, I. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00272 · Cited by 41
High levels of synaptosomal Na+–Ca2+ exchangers (NCX1, NCX2, NCX3) co-localized with amyloid-beta in human cerebral cortex affected by Alzheimer's disease
Sokolow, S., Luu, S. H., Headley, A. J., Hanson, A. Y., Kim, T., Miller, C. A., Vinters, H. V., & Gylys, K. H. (2011) · Cell Calcium · doi:10.1016/j.ceca.2010.12.008 · Cited by 41
Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA)
Brown, A. M., Sheu, R. K.-F., Mohs, R., Haroutunian, V., & Blass, J. P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:16:1:41 · Cited by 40
Pro-inflammatory effect of freshly solubilized β-amyloid peptides in the brain
Paris, D., Townsend, K. P., Obregon, D. F., Humphrey, J., & Mullan, M. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00111-9 · Cited by 40
From Soluble A β to Progressive A β Aggregation: Could Prion‐Like Templated Misfolding Play a Role?
Eisele, Y. S. (2013) · Brain Pathology · doi:10.1111/bpa.12049 · Cited by 43
High-Throughput Metabolomics for Discovering Potential Biomarkers and Identifying Metabolic Mechanisms in Aging and Alzheimer’s Disease
Xie, K., Qin, Q., Long, Z., Yang, Y., Peng, C., Xi, C., Li, L., Wu, Z., Daria, V., Zhao, Y., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.602887 · Cited by 41
What is the dominant aβ species in human brain tissue? A review
Gregory, G. C., & Halliday, G. M. (2005) · Neurotoxicity Research · doi:10.1007/bf03033774 · Cited by 41
Templating Effect of Lipid Membranes on Alzheimer's Amyloid Beta Peptide
Ege, C., Majewski, J. P., Wu, G., Kjær, K., & Lee, K. Y. C. (2005) · ChemPhysChem · doi:10.1002/cphc.200400468 · Cited by 40
New developments in animal models of Alzheimer’s disease
Janus, C., Phinney, A. L., Chishti, M. A., & Westaway, D. A. (2001) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-001-0105-8 · Cited by 40
Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen
Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie · doi:10.1002/ange.200802808 · Cited by 41
Amyloid-β at sublethal level impairs BDNF-induced arc expression in cortical neurons
Wang, D., Chen, S.-S., Lee, Y., & Chen, T. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.057 · Cited by 40
Imaging β-amyloid fibrils in Alzheimer's disease: a critical analysis through simulation of amyloid fibril polymerization
Shoghi, K. I., Barrio, J. R., Kepe, V., Wu, H.-M., Small, G. W., Phelps, M. E., & Huang, S. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.02.003 · Cited by 40
Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1
Vercauteren, F., Clerens, S., Roy, L., Hamel, N., Arckens, L., Vandesande, F., Alhonen, L. I., Jänne, J., Szyf, M., & Cuello, A. C. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.10.012 · Cited by 40
Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease
Campbell, S. N., Zhang, C., Roe, A. D., Lee, N., Lao, K., Monte, L., Donohue, M., & Rissman, R. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142844 · Cited by 39
Age-related changes in synaptic markers and monocyte subsets link the cognitive decline of APPSwe/PS1 mice
Naert, G., & Rivest, S. (2012) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2012.00051 · Cited by 42
MRI Evidence of Neuropathic Changes in Former College Football Players
Adler, C. M., DelBello, M. P., Weber, W., Williams, M., Durán, L. R. P., Fleck, D. E., Boespflug, E. L., Eliassen, J. C., Strakowski, S. M., & Divine, J. G. (2016) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000000391 · Cited by 39
Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
Wısnıewskı, T., & Boutajangout, A. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0236-2 · Cited by 39
A$beta;1-15 is less immunogenic than A$beta;1-40/42 for intranasal immunization of wild-type mice but may be effective for ?boosting?
Leverone, J. F. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00754-5 · Cited by 39
Alzheimer’s Disease: Genes, Pathogenesis and Risk Prediction
Sleegers, K., & van Duijn, C. M. (2001) · Public Health Genomics · doi:10.1159/000064193 · Cited by 39
In vivo cerebrovascular actions of amyloid β-peptides and the protective effect of conjugated estrogens
Rhodin, J. A. G., Thomas, T. N., Clark, L. C., Garces, A. H., & Bryant, M. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5403 · Cited by 40
Terahertz Spectroscopic Differentiation of Microstructures in Protein Gels
Png, G. M., Falconer, R. J., Fischer, B. M., Zakaria, H. A., Mickan, S. P., Middelberg, A. P. J., & Abbott, D. (2009) · Optics Express · doi:10.1364/oe.17.013102 · Cited by 38
Heme and hemoglobin suppress amyloid β–mediated inflammatory activation of mouse astrocytes
Sankar, S. B., Donegan, R. K., Shah, K. J., Reddi, A. R., & Wood, L. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001050 · Cited by 41
The Effects of Soluble A.β Oligomers on Neurodegeneration in Alzheimer's Disease
Brouillette, J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990498 · Cited by 39
NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice
Müller, M., Jacobi, E., Sakimura, K., Malinow, R., & von Engelhardt, J. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0611-4 · Cited by 40
“What Doesn’t Kill You Makes You Stronger”: Future Applications of Amyloid Aggregates in Biomedicine
Abdelrahman, S., Alghrably, M., Lachowicz, J. I., Emwas, A.-H. M., Hauser, C. A. E., & Jaremko, M. (2020) · Molecules · doi:10.3390/molecules25225245 · Cited by 38
Advances on the Understanding of the Origins of Synaptic Pathology in AD
Lacor, P. N. (2007) · Current Genomics · doi:10.2174/138920207783769530 · Cited by 40
Regional Variations in the Transport of Interleukin-1α across the Blood-Brain Barrier in ICR and Aging SAMP8 Mice
Moinuddin, A., Morley, J. E., & Banks, W. A. (2000) · NeuroImmunoModulation · doi:10.1159/000054814 · Cited by 38
Allelic Variation of Calsyntenin 2 (CLSTN2) Modulates the Impact of Developmental Tobacco Smoke Exposure on Mnemonic Processing in Adolescents
Jacobsen, L. K., Picciotto, M. R., Heath, C. J., Mencl, W. E., & Gelernter, J. E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.024 · Cited by 38
Neutron Scattering Studies of the Interplay of Amyloid β Peptide(1–40) and An Anionic Lipid 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol
Rai, D. K., Sharma, V. K., Anunciado, D. B., O’Neill, H., Mamontov, E., Urban, V. S., Heller, W. T., & Qian, S. (2016) · Scientific Reports · doi:10.1038/srep30983 · Cited by 38
Spotlight on BACE: The secretases as targets for treatment in Alzheimer disease
Dingwall, C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14402 · Cited by 38
Age-related increase in amyloid plaque burden is associated with impairment in conditioned fear memory in CRND8 mouse model of amyloidosis
Hanna, A., Iremonger, K., Das, P., Dickson, D., Golde, T., & Janus, C. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt124 · Cited by 38
Interactions between Aβ oligomers and presynaptic cholinergic signaling: Age-dependent effects on attentional capacities
Parikh, V., Bernard, C. S., Naughton, S. X., & Yegla, B. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.046 · Cited by 37
Dementia-linked amyloidosis is associated with brain protein deamidation as revealed by proteomic profiling of human brain tissues
Adav, S. S., Gallart‐Palau, X., Tan, K. H., Lim, S. K., Tam, J. P., & Sze, S. K. (2016) · Molecular Brain · doi:10.1186/s13041-016-0200-z · Cited by 38
The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ
Philipson, O., Lord, A., Lalowski, M. M., Soliymani, R., Baumann, M., Thyberg, J., Bogdanović, N., Olofsson, T., Tjernberg, L. O., Ingelsson, M., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.022 · Cited by 40
Cell-derived soluble oligomers of human amyloid-β peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons
Yang, T.-T., Hsu, C.-T., & Kuo, Y. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0311-0 · Cited by 38
Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: The impact of quantitative magnetization transfer MR imaging
Kiefer, C., Brockhaus, L., Cattapan-Ludewig, K., Ballinari, P., Burren, Y., Schroth, G., & Wiest, R. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.005 · Cited by 39
LPYFDa Neutralizes Amyloid-β-Induced Memory Impairment and Toxicity
Granic, I., Masman, M. F., Mulder, C. K., Nijholt, I. M., Naudé, P., de Haan, A., Borbély, E., Penke, B., Luiten, P. G. M., & Eisel, U. L. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1297 · Cited by 37
Botanical Sources for Alzheimer’s: A Review on Reports From Traditional Persian Medicine
Hosseinkhani, A., Sahragard, A., Namdari, A., & Zarshenas, M. M. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517717013 · Cited by 37
βAPP and Furin mRNA Concentrates in Immature Senile Plaques in the Brain of Alzheimer Patients
Marcinkiewicz, M. M. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.9.915 · Cited by 37
Structural differences in amyloid-β fibrils from brains of nondemented elderly individuals and Alzheimer's disease patients
Ghosh, U., Yau, W., Collinge, J., & Tycko, R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111863118 · Cited by 38
Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome
Schupf, N., Lee, A., Park, N., Dang, L. T., Pang, D. I., Yale, A., Oh, D. K. T., Krinsky‐McHale, S. J., Jenkins, E. C., Luchsinger, J. A., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.020 · Cited by 36
Cationization increases brain distribution of an amyloid-beta protofibril selective F(ab’)2 fragment
Syvänen, S., Edén, D., & Sehlin, D. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.065 · Cited by 36
Improvement of Olfactory Function With High Frequency Non-invasive Auricular Electrostimulation in Healthy Humans
Maharjan, A., Wang, E., Peng, M., & Çakmak, Y. Ö. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00225 · Cited by 39
A mechanistic link between oxidative stress and membrane mediated amyloidogenesis revealed by infrared spectroscopy
Komatsu, H., Liu, L., Murray, I. V. J., & Axelsen, P. H. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.05.026 · Cited by 36
Soluble Aβ homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins
Matsubara, E., Sekijima, Y., Tokuda, T., Urakami, K., Amari, M., Shizuka‐Ikeda, M., Tomidokoro, Y., Ikeda, M., Kawarabayashi, T., Harigaya, Y., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.10.004 · Cited by 36
Attenuation of Aβ deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking
COURT, J. A., Johnson, M., Religa, D., Keverne, J., Kalaria, R. N., Jaros, E., McKeith, I. G., Perry, R., Näslund, J., & Perry, E. K. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00674.x · Cited by 36
Self-citation
Characterization of the Alzheimer's Disease-associated CLAC Protein and Identification of an Amyloid β-Peptide-binding Site
Söderberg, L., Kakuyama, H., Möller, A., Itô, A., Winblad, B. G., Tjernberg, L. O., & Näslund, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403628200 · Cited by 36
Self-citation
Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue
Martins, R. N., Taddei, K., Kendall, C. L., Evin, G. M., Bates, K. A., & Harvey, A. R. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00289-5 · Cited by 36
Changing the Course of Alzheimer's Disease
Christensen, D. D. (2007) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v09n0106 · Cited by 37
Dementia Update 2003
Morris, J. C. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200310000-00010 · Cited by 36
Targeting α7 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug development
Burns, L. H., Pei, Z., & Wang, H. (2023) · Drug Development Research · doi:10.1002/ddr.22085 · Cited by 35
Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?
Silvestro, S., Valeri, A., & Mazzon, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042011 · Cited by 37
Brain cholinesterases: III. Future perspectives of AD research and clinical practice
Shen, Z. X. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.001 · Cited by 35
Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β1–42
Janíčková, H., Rudajev, V., Zimčík, P., Jakubík, J., Tanila, H., El‐Fakahany, E. E., & Doležal, V. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.014 · Cited by 37
The Contingency of Contingent Valuation How Much Are People Willing to Pay against Alzheimer's Disease?
Nocera, S., Bonato, D., & Telser, H. (2002) · International Journal of Health Care Finance and Economics · doi:10.1023/a:1020441726964 · Cited by 35
Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease
Wang, F., Gordon, B. A., Ryman, D. C., Ma, S., Xiong, C., Hassenstab, J. J., Goate, A., Fagan, A. M., Cairns, N. J., Marcus, D. S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001903 · Cited by 34
VSNL1 Co-Expression Networks in Aging Include Calcium Signaling, Synaptic Plasticity, and Alzheimer’s Disease Pathways
Lin, C., Chang, L., Tseng, G. C., Kirkwood, C. M., Sibille, E. L., & Sweet, R. A. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00030 · Cited by 35
Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer’s disease
Wu, K., Gao, X., Shi, B., Chen, S., Zhou, X., Li, Z., Gan, Y., Cui, L., Kang, J. X., Li, W., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.07.038 · Cited by 34
New Th2 adjuvants for preventive and active immunotherapy of neurodegenerative proteinopathies
Marciani, D. J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.015 · Cited by 34

Authors: Näslund, J.
Affiliations: Rockefeller University (US)
Corresponding author: Näslund, Jan
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2000-03-22
Volume: 283
Issue: 12
Pages: 1571
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.283.12.1571
OpenAlex: W2000706612
Cited by: 1,268
References: 28
Citations by year: 2026: 9 · 2025: 14 · 2024: 32 · 2023: 23 · 2022: 28 · 2021: 32 · 2020: 31 · 2019: 29 · 2018: 34 · 2017: 29 · 2016: 57 · 2015: 56 · 2014: 60 · 2013: 59 · 2012: 65
FWCI: 40.95
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (AG-02219, AG 05138, P50AG005138, AG 14996, P01AG002219)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: amyloid-beta, Alzheimer's disease, cognitive decline, dementia progression, tau protein, amyloid-beta 42, Aβ40, frontal cortex, Clinical Dementia Rating, postmortem brain, neocortex, nursing home residents, amyloid plaques, neurofibrillary tangles
MeSH terms: Aged, Aged, 80 and over, Brain, Cognition Disorders, Cross-Sectional Studies, Dementia, Enzyme-Linked Immunosorbent Assay, Female, Frontal Lobe, Humans, Immunoenzyme Techniques, Male, Immunoblotting, Amyloid beta-Peptides, tau Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks